An in-depth look to MEDEON BIODESIGN INC operating, investing, and financing activities

6499 free cash flow for Q3 24 is -251.25 M TWD. For 2023, 6499 free cash flow was -802.98 M TWD and operating cash flow was -747.69 M TWD.